DNA vaccine VGX-3100 with electroporation induces regression of cervical intraepithelial neoplasia 2/3 and clears HPV infection with robust T cell responses: results of a randomized, double-blind, placebo-controlled Phase II trial
Gespeichert in:
| Veröffentlicht in: | Journal for immunotherapy of cancer 2014-11, Vol.2 (S3), p.O17-O17, Article O17 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | O17 |
|---|---|
| container_issue | S3 |
| container_start_page | O17 |
| container_title | Journal for immunotherapy of cancer |
| container_volume | 2 |
| creator | Humeau, Laurent Trimble, Cornelia Morrow, Matthew Shen, Xuefei Dallas, Michael Weiner, David Boyer, Jean Yan, Jian Kraynyak, Kimberly Sylvester, Albert Giffear, Mary Marcozzi-Pierce, Kathy Shah, Divya Broderick, Kate Khan, Amir Lee, Jessica Sardesai, Niranjan Bargarazzi, Mark |
| description | |
| doi_str_mv | 10.1186/2051-1426-2-S3-O17 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4288328</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2638111794</sourcerecordid><originalsourceid>FETCH-LOGICAL-b2817-96912a53183977048f74d3a17002d60c72548f3203a086f4472e008cc8e39c373</originalsourceid><addsrcrecordid>eNp1kttO3DAQhiPUSiDKC_TKEre4-JCNnV5UQpTDSqggQRF3luNMWCNvJrWTrdoH7nPU6SJUpPbK45nx9__2uCjec_aBc10dC7bglJeiooLeSnrN1U6x95J881e8Wxyk9MQY40xKrfVe8evzlxOysc75Hsj9xQOVnDHy3Y8rAgHcGHHAaEePPfF9OzlIJMJjhJTmFHbEQdx4Z0Muj9HCkE9C8HnfAw7BJm-JOJbE9i1xAWxM5PLmPjd3GT4j_khFbKY0krtMCyELpAH7BOnjHE5hTLOQJTFDcO1_QntEWpyaALQJ2dURyUIOGqQOswkMAVpys7IJyHJJxpjdvCvedjYkOHhe94uv52d3p5f06vpieXpyRRuhuaJ1VXNhF5JrWSvFSt2pspWWK8ZEWzGnxCLnpGDSMl11ZakEMKad0yBrJ5XcLz5tucPUrKF1MD9KMEP0axt_GLTevK70fmUecWNKobUUOgPOtoDG438ArysO12aer5nna4S5lSZ_gMw5fDYS8dsEaTRPOMU-392ISmrOuarL3CW2XS5iShG6FyHOzPy3_oX-DYbGxWk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2638111794</pqid></control><display><type>article</type><title>DNA vaccine VGX-3100 with electroporation induces regression of cervical intraepithelial neoplasia 2/3 and clears HPV infection with robust T cell responses: results of a randomized, double-blind, placebo-controlled Phase II trial</title><source>BMJ Open Access Journals</source><source>DOAJ Directory of Open Access Journals</source><source>Springer Nature OA Free Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Humeau, Laurent ; Trimble, Cornelia ; Morrow, Matthew ; Shen, Xuefei ; Dallas, Michael ; Weiner, David ; Boyer, Jean ; Yan, Jian ; Kraynyak, Kimberly ; Sylvester, Albert ; Giffear, Mary ; Marcozzi-Pierce, Kathy ; Shah, Divya ; Broderick, Kate ; Khan, Amir ; Lee, Jessica ; Sardesai, Niranjan ; Bargarazzi, Mark</creator><creatorcontrib>Humeau, Laurent ; Trimble, Cornelia ; Morrow, Matthew ; Shen, Xuefei ; Dallas, Michael ; Weiner, David ; Boyer, Jean ; Yan, Jian ; Kraynyak, Kimberly ; Sylvester, Albert ; Giffear, Mary ; Marcozzi-Pierce, Kathy ; Shah, Divya ; Broderick, Kate ; Khan, Amir ; Lee, Jessica ; Sardesai, Niranjan ; Bargarazzi, Mark ; the HPV-003 Protocol team</creatorcontrib><identifier>ISSN: 2051-1426</identifier><identifier>EISSN: 2051-1426</identifier><identifier>DOI: 10.1186/2051-1426-2-S3-O17</identifier><language>eng</language><publisher>London: BMJ Publishing Group LTD</publisher><subject>Double-blind studies ; Human papillomavirus ; Oral Presentation ; Vaccines</subject><ispartof>Journal for immunotherapy of cancer, 2014-11, Vol.2 (S3), p.O17-O17, Article O17</ispartof><rights>2014 Humeau et al.; licensee BioMed Central Ltd This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/4.0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/ ) applies to the data made available in this article, unless otherwise stated. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright © 2014 Humeau et al.; licensee BioMed Central Ltd. 2014 Humeau et al.; licensee BioMed Central Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b2817-96912a53183977048f74d3a17002d60c72548f3203a086f4472e008cc8e39c373</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288328/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288328/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27924,27925,53791,53793</link.rule.ids></links><search><creatorcontrib>Humeau, Laurent</creatorcontrib><creatorcontrib>Trimble, Cornelia</creatorcontrib><creatorcontrib>Morrow, Matthew</creatorcontrib><creatorcontrib>Shen, Xuefei</creatorcontrib><creatorcontrib>Dallas, Michael</creatorcontrib><creatorcontrib>Weiner, David</creatorcontrib><creatorcontrib>Boyer, Jean</creatorcontrib><creatorcontrib>Yan, Jian</creatorcontrib><creatorcontrib>Kraynyak, Kimberly</creatorcontrib><creatorcontrib>Sylvester, Albert</creatorcontrib><creatorcontrib>Giffear, Mary</creatorcontrib><creatorcontrib>Marcozzi-Pierce, Kathy</creatorcontrib><creatorcontrib>Shah, Divya</creatorcontrib><creatorcontrib>Broderick, Kate</creatorcontrib><creatorcontrib>Khan, Amir</creatorcontrib><creatorcontrib>Lee, Jessica</creatorcontrib><creatorcontrib>Sardesai, Niranjan</creatorcontrib><creatorcontrib>Bargarazzi, Mark</creatorcontrib><creatorcontrib>the HPV-003 Protocol team</creatorcontrib><title>DNA vaccine VGX-3100 with electroporation induces regression of cervical intraepithelial neoplasia 2/3 and clears HPV infection with robust T cell responses: results of a randomized, double-blind, placebo-controlled Phase II trial</title><title>Journal for immunotherapy of cancer</title><subject>Double-blind studies</subject><subject>Human papillomavirus</subject><subject>Oral Presentation</subject><subject>Vaccines</subject><issn>2051-1426</issn><issn>2051-1426</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNp1kttO3DAQhiPUSiDKC_TKEre4-JCNnV5UQpTDSqggQRF3luNMWCNvJrWTrdoH7nPU6SJUpPbK45nx9__2uCjec_aBc10dC7bglJeiooLeSnrN1U6x95J881e8Wxyk9MQY40xKrfVe8evzlxOysc75Hsj9xQOVnDHy3Y8rAgHcGHHAaEePPfF9OzlIJMJjhJTmFHbEQdx4Z0Muj9HCkE9C8HnfAw7BJm-JOJbE9i1xAWxM5PLmPjd3GT4j_khFbKY0krtMCyELpAH7BOnjHE5hTLOQJTFDcO1_QntEWpyaALQJ2dURyUIOGqQOswkMAVpys7IJyHJJxpjdvCvedjYkOHhe94uv52d3p5f06vpieXpyRRuhuaJ1VXNhF5JrWSvFSt2pspWWK8ZEWzGnxCLnpGDSMl11ZakEMKad0yBrJ5XcLz5tucPUrKF1MD9KMEP0axt_GLTevK70fmUecWNKobUUOgPOtoDG438ArysO12aer5nna4S5lSZ_gMw5fDYS8dsEaTRPOMU-392ISmrOuarL3CW2XS5iShG6FyHOzPy3_oX-DYbGxWk</recordid><startdate>20141106</startdate><enddate>20141106</enddate><creator>Humeau, Laurent</creator><creator>Trimble, Cornelia</creator><creator>Morrow, Matthew</creator><creator>Shen, Xuefei</creator><creator>Dallas, Michael</creator><creator>Weiner, David</creator><creator>Boyer, Jean</creator><creator>Yan, Jian</creator><creator>Kraynyak, Kimberly</creator><creator>Sylvester, Albert</creator><creator>Giffear, Mary</creator><creator>Marcozzi-Pierce, Kathy</creator><creator>Shah, Divya</creator><creator>Broderick, Kate</creator><creator>Khan, Amir</creator><creator>Lee, Jessica</creator><creator>Sardesai, Niranjan</creator><creator>Bargarazzi, Mark</creator><general>BMJ Publishing Group LTD</general><general>BioMed Central Ltd</general><general>BioMed Central</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope></search><sort><creationdate>20141106</creationdate><title>DNA vaccine VGX-3100 with electroporation induces regression of cervical intraepithelial neoplasia 2/3 and clears HPV infection with robust T cell responses: results of a randomized, double-blind, placebo-controlled Phase II trial</title><author>Humeau, Laurent ; Trimble, Cornelia ; Morrow, Matthew ; Shen, Xuefei ; Dallas, Michael ; Weiner, David ; Boyer, Jean ; Yan, Jian ; Kraynyak, Kimberly ; Sylvester, Albert ; Giffear, Mary ; Marcozzi-Pierce, Kathy ; Shah, Divya ; Broderick, Kate ; Khan, Amir ; Lee, Jessica ; Sardesai, Niranjan ; Bargarazzi, Mark</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b2817-96912a53183977048f74d3a17002d60c72548f3203a086f4472e008cc8e39c373</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Double-blind studies</topic><topic>Human papillomavirus</topic><topic>Oral Presentation</topic><topic>Vaccines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Humeau, Laurent</creatorcontrib><creatorcontrib>Trimble, Cornelia</creatorcontrib><creatorcontrib>Morrow, Matthew</creatorcontrib><creatorcontrib>Shen, Xuefei</creatorcontrib><creatorcontrib>Dallas, Michael</creatorcontrib><creatorcontrib>Weiner, David</creatorcontrib><creatorcontrib>Boyer, Jean</creatorcontrib><creatorcontrib>Yan, Jian</creatorcontrib><creatorcontrib>Kraynyak, Kimberly</creatorcontrib><creatorcontrib>Sylvester, Albert</creatorcontrib><creatorcontrib>Giffear, Mary</creatorcontrib><creatorcontrib>Marcozzi-Pierce, Kathy</creatorcontrib><creatorcontrib>Shah, Divya</creatorcontrib><creatorcontrib>Broderick, Kate</creatorcontrib><creatorcontrib>Khan, Amir</creatorcontrib><creatorcontrib>Lee, Jessica</creatorcontrib><creatorcontrib>Sardesai, Niranjan</creatorcontrib><creatorcontrib>Bargarazzi, Mark</creatorcontrib><creatorcontrib>the HPV-003 Protocol team</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal for immunotherapy of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Humeau, Laurent</au><au>Trimble, Cornelia</au><au>Morrow, Matthew</au><au>Shen, Xuefei</au><au>Dallas, Michael</au><au>Weiner, David</au><au>Boyer, Jean</au><au>Yan, Jian</au><au>Kraynyak, Kimberly</au><au>Sylvester, Albert</au><au>Giffear, Mary</au><au>Marcozzi-Pierce, Kathy</au><au>Shah, Divya</au><au>Broderick, Kate</au><au>Khan, Amir</au><au>Lee, Jessica</au><au>Sardesai, Niranjan</au><au>Bargarazzi, Mark</au><aucorp>the HPV-003 Protocol team</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>DNA vaccine VGX-3100 with electroporation induces regression of cervical intraepithelial neoplasia 2/3 and clears HPV infection with robust T cell responses: results of a randomized, double-blind, placebo-controlled Phase II trial</atitle><jtitle>Journal for immunotherapy of cancer</jtitle><date>2014-11-06</date><risdate>2014</risdate><volume>2</volume><issue>S3</issue><spage>O17</spage><epage>O17</epage><pages>O17-O17</pages><artnum>O17</artnum><issn>2051-1426</issn><eissn>2051-1426</eissn><cop>London</cop><pub>BMJ Publishing Group LTD</pub><doi>10.1186/2051-1426-2-S3-O17</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2051-1426 |
| ispartof | Journal for immunotherapy of cancer, 2014-11, Vol.2 (S3), p.O17-O17, Article O17 |
| issn | 2051-1426 2051-1426 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4288328 |
| source | BMJ Open Access Journals; DOAJ Directory of Open Access Journals; Springer Nature OA Free Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central |
| subjects | Double-blind studies Human papillomavirus Oral Presentation Vaccines |
| title | DNA vaccine VGX-3100 with electroporation induces regression of cervical intraepithelial neoplasia 2/3 and clears HPV infection with robust T cell responses: results of a randomized, double-blind, placebo-controlled Phase II trial |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T04%3A43%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=DNA%20vaccine%20VGX-3100%20with%20electroporation%20induces%20regression%20of%20cervical%20intraepithelial%20neoplasia%202/3%20and%20clears%20HPV%20infection%20with%20robust%20T%20cell%20responses:%20results%20of%20a%20randomized,%20double-blind,%20placebo-controlled%20Phase%20II%20trial&rft.jtitle=Journal%20for%20immunotherapy%20of%20cancer&rft.au=Humeau,%20Laurent&rft.aucorp=the%20HPV-003%20Protocol%20team&rft.date=2014-11-06&rft.volume=2&rft.issue=S3&rft.spage=O17&rft.epage=O17&rft.pages=O17-O17&rft.artnum=O17&rft.issn=2051-1426&rft.eissn=2051-1426&rft_id=info:doi/10.1186/2051-1426-2-S3-O17&rft_dat=%3Cproquest_pubme%3E2638111794%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2638111794&rft_id=info:pmid/&rfr_iscdi=true |